After more than a quarter-century on one of South Carolina’s most influential corporate boards, Judge Merl Code should face a simple question: Who is holding the directors accountable?
Judge Merl Code has built an impressive résumé. A former football player who later pursued a legal career, Code made history in 1981 when he became the first African American to serve as a Municipal Court Judge in Greenville, South Carolina.
His career has included numerous distinctions. He received the Order of the Palmetto, South Carolina’s highest civilian honor, in 1996; the Compleat Lawyer Award from the South Carolina Bar in 1997; and recognition in the South Carolina Black Hall of Fame in 1999. He also became the first African American chairman of the Greenville Chamber of Commerce in 1999.
Beyond the courtroom and boardroom, Code has been involved in several business ventures, including Precision Tool Manufacturer, Code Insurance Associates, and Code & Associates, a sports management agency.
His accomplishments deserve recognition. But a distinguished résumé should not place anyone beyond scrutiny.
And that brings us to his long tenure on the board of directors of BlueCross BlueShield of South Carolina.
Twenty-six years. Twenty-six opportunities for accountability.
Judge Merl Code has served on the BlueCross BlueShield of South Carolina board of directors since 2000. That is approximately 26 years of continuous board service.
This is no ordinary corporate board. BlueCross BlueShield of South Carolina plays an enormous role in the healthcare system, affecting the financial and medical well-being of millions of South Carolinians. Its decisions can have significant consequences for policyholders, employers, healthcare providers, and families.
Board members have important responsibilities, including oversight of corporate strategy, executive leadership, financial performance, and major business decisions.
Yet how much do ordinary policyholders know about the individuals making these decisions?
How many could identify Judge Merl Code as one of the company’s longtime directors? How many know how he votes on significant issues? How many have ever heard him publicly explain his position on healthcare affordability, premium increases, or corporate accountability?
These are legitimate questions, particularly when someone has occupied a board seat for more than two decades with zero healthcare experience.
Is this really an election, or simply a recurring formality?
One of the most important issues deserving public scrutiny is the board’s director nomination and election process.
If, as available accounts suggest, Code has repeatedly been nominated without facing competing candidates, then describing his tenure as the product of 26 consecutive competitive elections would be misleading.
There is a fundamental difference between winning a genuinely contested election and being the only candidate presented to voters for 26 years in a row.
If the nomination process effectively limits who can qualify for a board seat, where is the meaningful opportunity for new candidates to participate?
Who decides which candidates get nominated? Can policyholders independently nominate qualified alternatives? What safeguards ensure that board elections provide genuine choices rather than merely formal approval of management’s preferred candidates?
These questions deserve clear answers.
A board election should not become a procedural exercise in which the same individuals remain in power simply because nobody else is permitted, encouraged, or realistically positioned to challenge them.
If Code has faced no opposition throughout his tenure, the public deserves to understand why.
Where is the voting record?
Perhaps the most important question is also the simplest:
How has Merl Code voted during his 26 years on the board?
Has he challenged management proposals? Has he questioned executive compensation? Has he raised concerns about premium affordability? Has he opposed any major corporate decisions? Has he advocated for policyholders when their interests might conflict with corporate financial objectives?
The public should not have to guess.
A director’s job is not simply to attend meetings, collect compensation, and approve whatever management places before the board. Directors are entrusted with independent judgment and meaningful oversight.
I would like to see a comprehensive record of Code’s participation, attendance, committee assignments, disclosures, and voting history, to the extent these records can legally be made available.
If he has consistently challenged management and advocated for policyholders, that record should speak for itself.
But if his role has largely been ceremonial, that raises a different set of questions about the purpose of long-term board appointments and the effectiveness of corporate governance.
Transparency should not be an unreasonable demand.
The compensation question
Corporate board service can be financially rewarding. Directors at major companies may receive substantial compensation for their time and responsibilities.
Code’s compensation from BlueCross BlueShield of South Carolina deserves public scrutiny, particularly in light of his extraordinary length of service.
What is his annual compensation? How much is paid in cash, stock, or other benefits? How many board and committee meetings does he attend? What additional responsibilities does he perform?
These figures should be examined through the company’s available financial disclosures rather than assumptions.
When a company makes decisions that affect the healthcare costs of millions of people, policyholders have a legitimate interest in understanding how its directors are compensated and what accountability accompanies that compensation.
Experience should not become permanent entitlement
At approximately 78 years old, Code has had a long career in law, business, public service, and corporate leadership.
His historical achievements, particularly as an African American pioneer in Greenville, deserve respect. Nothing in this argument diminishes the significance of breaking racial barriers or the contributions he has made throughout his career.
But recognition for past accomplishments should not translate into an indefinite claim on positions of corporate influence.
Board membership should be about the needs of the institution and the interests of those it serves—not the length of time an individual has occupied a seat.
After 26 years, it is reasonable to ask whether the board would benefit from new perspectives, greater competition, and a more transparent nomination process.
South Carolina has no shortage of younger attorneys, business executives, financial professionals, healthcare experts, and community leaders who could bring fresh ideas and different experiences to the table.
Why shouldn’t they have a meaningful opportunity to compete for these positions?
An invitation to step aside
This is not a personal attack on Judge Merl Code. It is an argument about corporate accountability, board renewal, and the public’s right to question institutions that exercise enormous influence over their lives.
I respectfully believe that after approximately 26 years on the BlueCross BlueShield of South Carolina board, Code should seriously consider stepping aside and allowing a new generation of qualified leaders to compete for his position.
If he chooses to remain, he should welcome questions about his voting record, compensation, attendance, and contributions to the board.
The company, meanwhile, should explain its nomination procedures and demonstrate that its board elections offer meaningful opportunities for qualified challengers.
No director should be immune from scrutiny simply because he has served for a long time or has an impressive professional history.
Judge Merl Code has already made history. His legacy as a trailblazer is established.
But corporate board seats are not lifetime appointments, and past accomplishments do not eliminate the responsibility to demonstrate present-day accountability.
Twenty-six years is a remarkable tenure. It is also a reasonable point at which to ask whether it is time for someone new to take a seat at the table.
South Carolina’s policyholders deserve a board that welcomes scrutiny, encourages competition, and remembers whom it ultimately serves.
#JudgeMerlCode #BlueCrossBlueShieldSC #CorporateAccountability #BoardTransparency #CorporateGovernance #HealthcareAccountability #SouthCarolina #SCPolicyholders #BoardTermLimits #LeadershipAccountability #TransparencyMatters #HealthcareAffordability #ShareholderRights #BoardroomAccountability #TimeForNewLeadership #PublicAccountability #SouthCarolinaPolitics #CorporateOversight #26YearsIsEnough #FreshPerspectives
No comments:
Post a Comment